Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer

The expanded use of second-generation antiandrogens revolutionized the treatment landscape of progressed prostate cancer. However, resistances to these novel drugs are already the next obstacle to be solved. Various previous studies depicted an involvement of the enzyme AKR1C3 in the process of cast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Kafka, Mona, Mayr, Fabian, Temml, Veronika, Möller, Gabriele, Adamski, Jerzy, Höfer, Julia, Schwaiger, Stefan, Heidegger, Isabel, Matuszczak, Barbara, Schuster, Daniela, Klocker, Helmut, Bektic, Jasmin, Stuppner, Hermann, Eder, Iris E.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465893/
https://ncbi.nlm.nih.gov/pubmed/32731472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados